Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.12 B1.1 B1.15 B1.24 B1.19 B 4.68 B Research & development ————— — Operating income 5.28 B5.32 B5.6 B5.19 B5.41 B 21.51 B Non-Operating Income, Total 44 M-13 M38 M3 M22 M 50 M Interest expense, net of interest capitalized 3.42 B3.55 B3.71 B3.64 B3.58 B 14.47 B Non-Operating Income, excl. Interest Expenses -3.38 B-3.57 B-3.67 B-3.64 B-3.55 B -14.42 B Unusual income/expense ————— — Pretax income 2.16 B2.29 B2.53 B2.53 B2.42 B 9.78 B Equity in earnings ————— — Taxes 443 M472 M524 M482 M469 M 1.95 B Non-controlling/minority interest 7 M6 M7 M6 M5 M 24 M After tax other income/expense ————— — Net income before discontinued operations 1.71 B1.81 B2 B2.04 B1.95 B 7.81 B Discontinued operations ————— — Net income 1.71 B1.81 B2 B2.04 B1.95 B 7.81 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 1.6 B1.73 B1.89 B1.97 B1.84 B 7.43 B Basic earnings per share (Basic EPS) 1.031.111.221.261.18 4.77 Diluted earnings per share (Diluted EPS) 1.031.111.221.261.18 4.77 Average basic shares outstanding 1.56 B1.56 B1.56 B1.56 B1.55 B — Diluted shares outstanding 1.56 B1.56 B1.56 B1.56 B1.55 B — EBITDA 5.3 B5.34 B5.6 B5.56 B5.49 B 21.99 B EBIT 5.09 B5.12 B5.38 B4.96 B5.29 B 20.75 B Cost of revenue 537 M501 M571 M577 M576 M 2.23 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 215 M217 M216 M599 M204 M 1.24 B